matdesign24/iStock via Getty Images Regencell Bioscience ( RGC ), a Hong Kong-based biopharma focused on traditional Chinese medicine, announced on Friday that its directors and employees have agreed to further extend lock-up expirations related to their previously granted stock options. As a result, all employees and directors with those stock options will see their lock-up undertakings extending...
matdesign24/iStock via Getty Images Regencell Bioscience ( RGC ), a Hong Kong-based biopharma focused on traditional Chinese medicine, announced on Friday that its directors and employees have agreed to further extend lock-up expirations related to their previously granted stock options. As a result, all employees and directors with those stock options will see their lock-up undertakings extending by another 12 months until Apr. 20, 2027, Regencell ( RGC ) said in a regulatory filing. Previously, their lock-up commitments and related extensions ran until April 20, 2026. The revised lock-up commitments are applicable to 82% to 92% of directors’ shares and vested share options, respectively, and 100% of employee shares and vested share options, according to the company. Regencell ( RGC ) saw its share price skyrocketing to $21 in 2025, with the company attributing the volatility to a short squeeze. More on Regencell Bioscience Holdings Regencell Bioscience: Cutting Costs Isn't Growth, It's Survival Regencell Bioscience: Material Weaknesses Add To Woes Regencell Bioscience is the top performing pharma stock YTD Seeking Alpha’s Quant Rating on Regencell Bioscience Holdings Financial information for Regencell Bioscience Holdings
In trading on Friday, shares of the Fidelity Enhanced Large Cap Growth ETF (Symbol: FELG) crossed below their 200 day moving average of $39.15, changing hands as low as $39.13 per share. Fidelity Enhanced Large Cap Growth shares are currently trading down about 0.2% on the day.
In trading on Friday, shares of the Fidelity Enhanced Large Cap Growth ETF (Symbol: FELG) crossed below their 200 day moving average of $39.15, changing hands as low as $39.13 per share. Fidelity Enhanced Large Cap Growth shares are currently trading down about 0.2% on the day.
In trading on Friday, shares of Bio-Rad Laboratories Inc (Symbol: BIO) crossed below their 200 day moving average of $281.97, changing hands as low as $251.00 per share. Bio-Rad Laboratories Inc shares are currently trading off about 11.7% on the day. The chart below shows the
In trading on Friday, shares of Bio-Rad Laboratories Inc (Symbol: BIO) crossed below their 200 day moving average of $281.97, changing hands as low as $251.00 per share. Bio-Rad Laboratories Inc shares are currently trading off about 11.7% on the day. The chart below shows the
In trading on Friday, shares of Artivion Inc (Symbol: AORT) crossed below their 200 day moving average of $38.61, changing hands as low as $33.85 per share. Artivion Inc shares are currently trading down about 6.5% on the day. The chart below shows the one year performance of
In trading on Friday, shares of Artivion Inc (Symbol: AORT) crossed below their 200 day moving average of $38.61, changing hands as low as $33.85 per share. Artivion Inc shares are currently trading down about 6.5% on the day. The chart below shows the one year performance of
imaginima/E+ via Getty Images Goldman Sachs said the sharp rally in U.S. energy equities this year does not mark the end of the trade, identifying 10 Buy-rated stocks that it believes still offer above-average upside despite the sector’s strong outperformance. The S&P 500 Energy ( XLE ) sector has climbed about 23% year to date, compared with a roughly 1% gain for the broader market, as investors ...
imaginima/E+ via Getty Images Goldman Sachs said the sharp rally in U.S. energy equities this year does not mark the end of the trade, identifying 10 Buy-rated stocks that it believes still offer above-average upside despite the sector’s strong outperformance. The S&P 500 Energy ( XLE ) sector has climbed about 23% year to date, compared with a roughly 1% gain for the broader market, as investors rotated into cyclicals amid firmer oil prices, improved growth expectations, and tighter-than-expected supply balances. The bank said the move has been driven by positive GDP revisions, a broader rotation out of technology, and geopolitical uncertainty supporting crude prices. Goldman continues to anchor valuations to a mid-cycle framework of $70 per barrel Brent and $3.75 per MMBtu Henry Hub and estimates its 10 highlighted names offer an average total return potential of about 19% from current levels. The list spans refining, global oils, exploration and production, midstream, oilfield services, and power generation. In refining, HF Sinclair ( DINO ) is favored for its balance sheet strength, non-refining earnings contributions, and capital return profile. Among global oils and upstream names, Goldman highlighted ConocoPhillips ( COP ) for its expected free cash flow inflection as major projects ramp up, while EQT Corporation ( EQT ), Viper Energy ( VNOM ), and Diamondback Energy ( FANG ) are considered offering attractive risk-reward on the back of low-cost inventory and shareholder return frameworks. In midstream and LNG, Kinder Morgan ( KMI ), Cheniere Energy ( LNG ), and Golar LNG ( GLNG ) are viewed as offering earnings visibility through contracted cash flows and project backlogs. In oilfield services, Halliburton ( HAL ) is considered positioned to benefit from improving international activity and margin expansion. In power generation, Vistra ( VST ) is expected to see upside from additional power purchase agreements and stable cash flows from its contracted fleet....
A rout in Hims & Hers Health Inc. has delivered a windfall to short sellers, as investors bet against the telehealth company’s business. Shares have tumbled more than 50% this year through Thursday’s close after Novo Nordisk A/S said it was suing the company to halt obesity-drug copycats. The decline has handed short sellers more than $1.3 billion in paper gains so far, according to S3 Partners ma...
A rout in Hims & Hers Health Inc. has delivered a windfall to short sellers, as investors bet against the telehealth company’s business. Shares have tumbled more than 50% this year through Thursday’s close after Novo Nordisk A/S said it was suing the company to halt obesity-drug copycats. The decline has handed short sellers more than $1.3 billion in paper gains so far, according to S3 Partners managing director Matthew Unterman . “Enthusiasm around weight loss offerings has given way to legal uncertainty following Novo Nordisk’s lawsuit targeting ‘copycat’ drugs,” Unterman wrote in a note to clients. Hims & Hers launched a copycat version of the new Wegovy weight-loss pill on Feb. 5, then reversed course a day later after the US Food and Drug Administration threatened to crack down on weight-loss drug knockoffs. Read More: Novo Says It’s Suing Hims to Halt Obesity Drug Copycats Short interest — a measure of how many shares have been borrowed and sold short — rose to a new 52-week high as of Feb. 11, topping 77 million shares.
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of
In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of
Investing.com -- The US Federal Trade Commission is stepping up its investigation into Microsoft Corp. over potential monopolistic practices in enterprise computing, cloud software, and AI offerings including Copilot, Bloomberg reported Friday.
Investing.com -- The US Federal Trade Commission is stepping up its investigation into Microsoft Corp. over potential monopolistic practices in enterprise computing, cloud software, and AI offerings including Copilot, Bloomberg reported Friday.
L’Oréal booth in Shanghai. Photo: VCG L’Oréal SA and The Estée Lauder Companies Inc., two of the world’s leading cosmetics firms, have reported a resurgence in sales in China, signaling a recovery in the crucial beauty market following a period of sluggish growth. On Thursday, L’Oréal, the French cosmetics powerhouse, announced full-year 2025 sales of 44.05 billion euros ($52 billion), a 4% increa...
L’Oréal booth in Shanghai. Photo: VCG L’Oréal SA and The Estée Lauder Companies Inc., two of the world’s leading cosmetics firms, have reported a resurgence in sales in China, signaling a recovery in the crucial beauty market following a period of sluggish growth. On Thursday, L’Oréal, the French cosmetics powerhouse, announced full-year 2025 sales of 44.05 billion euros ($52 billion), a 4% increase compared to the previous year. While noting robust recoveries in both the U.S. and China during the second half of the year, the company highlighted a sharp acceleration in sales growth across the Chinese mainland. After starting the year with low single-digit growth, L’Oréal reported a mid-single-digit rise in China during the second half of 2025, driving a 4% sales increase in the broader North Asia region for the period.
With 2026 being the year of the fire horse, this spicy number has a suitable kick to mark the occasion Here’s a spicy little number that will help you see in the lunar new year in style on 17 January. Rron Rakoci, mixologist, Huŏ , London Continue reading...
With 2026 being the year of the fire horse, this spicy number has a suitable kick to mark the occasion Here’s a spicy little number that will help you see in the lunar new year in style on 17 January. Rron Rakoci, mixologist, Huŏ , London Continue reading...
Designer Stella Jean forced to paint over image of revolutionary on ski suits after being told it breached rules Winter Olympics live – latest updates The designer behind the Haitian team’s uniform for the 2026 Winter Olympics has said she had to redesign their ski suits for the opening ceremony after being told they did not comply with the guidelines on athlete expression by the International Oly...
Designer Stella Jean forced to paint over image of revolutionary on ski suits after being told it breached rules Winter Olympics live – latest updates The designer behind the Haitian team’s uniform for the 2026 Winter Olympics has said she had to redesign their ski suits for the opening ceremony after being told they did not comply with the guidelines on athlete expression by the International Olympic Committee. The uniforms, designed by the Haitian-Italian designer Stella Jean, were based on a 2006 painting of the formerly enslaved revolutionary Toussaint Louverture riding a horse by the Haitian artist Edouard Duval-Carrié. Louverture, who led the successful revolt that established the world’s first Black republic in 1804, had been central to Jean’s initial design. Continue reading...
Goldman Sachs Group Inc. has rolled out a new custom basket aimed at navigating the growing upheaval in software stocks, betting on companies perceived to be better insulated from artificial intelligence disruption than others. The firm introduced a software pair trade basket that goes long companies whose businesses are seen as difficult for AI to displace — either because they require physical e...
Goldman Sachs Group Inc. has rolled out a new custom basket aimed at navigating the growing upheaval in software stocks, betting on companies perceived to be better insulated from artificial intelligence disruption than others. The firm introduced a software pair trade basket that goes long companies whose businesses are seen as difficult for AI to displace — either because they require physical execution, regulatory entrenchment, or human accountability — while shorting firms whose workflows AI could increasingly automate or replicate internally. On the long side, Goldman favors businesses that stand to benefit directly from rising AI adoption, including providers of compute, data infrastructure, observability, cybersecurity, hyperscale cloud and AI development platforms. The basket includes names such as Cloudflare Inc. , CrowdStrike Holdings Inc. , Palo Alto Networks Inc. , Oracle Corp. and Microsoft Corp. , among others. On the short side, traders targeted software-tilted workflows that could be automated or rebuilt in-house as AI capabilities expand. Those include Monday.com Ltd. , Salesforce Inc. , DocuSign Inc. , Accenture Plc and Duolingo Inc .. “We expect the long side of the basket recover from the recent software selloff while short part will lag behind,” Faris Mourad , Goldman’s vice president of the US custom baskets team, wrote in a note to clients. The launch comes as anxiety over AI’s disruptive potential intensifies. Last week, startup Anthropic PBC unveiled a productivity tool aimed at in-house legal teams, triggering a sharp selloff in legal software and publishing stocks. The selloff continued after little-known startup Altruist Corp. rolled out a tax-strategy tool sending shares of Charles Schwab Corp. and LPL Financial Holdings Inc. among others down by 10% or more over the past week. Wall Street’s skepticism toward software names has been building for months, but sentiment has recently shifted from cautious to outright defensive. Investors hav...
An undercover operative stopped Walid Saadaoui and Amar Hussein carrying out deadly terror attack Two men have been jailed for life after attempting to stage one of the UK’s deadliest terrorist attacks before it was thwarted by an undercover operative. Walid Saadaoui, 38, and Amar Hussein, 52, who had sworn allegiance to Islamic State (IS), planned a marauding firearms attack targeting Greater Man...
An undercover operative stopped Walid Saadaoui and Amar Hussein carrying out deadly terror attack Two men have been jailed for life after attempting to stage one of the UK’s deadliest terrorist attacks before it was thwarted by an undercover operative. Walid Saadaoui, 38, and Amar Hussein, 52, who had sworn allegiance to Islamic State (IS), planned a marauding firearms attack targeting Greater Manchester’s Jewish community. Continue reading...
Watch: Sen. Johnson Unloads On MN AG Ellison Over Anti-ICE Agitator Deaths Authored by Steve Watson via Modernity.news, Viral footage from a Senate hearing captures Wisconsin Sen. Ron Johnson tearing into Minnesota Attorney General Keith Ellison for allegedly exploiting and encouraging anti-ICE agitators whose actions led to deadly clashes with federal agents. This raw exchange highlights the esca...
Watch: Sen. Johnson Unloads On MN AG Ellison Over Anti-ICE Agitator Deaths Authored by Steve Watson via Modernity.news, Viral footage from a Senate hearing captures Wisconsin Sen. Ron Johnson tearing into Minnesota Attorney General Keith Ellison for allegedly exploiting and encouraging anti-ICE agitators whose actions led to deadly clashes with federal agents. This raw exchange highlights the escalating tensions over leftist obstruction of Trump’s deportation efforts, putting law enforcement in the crosshairs while shielding criminal illegal aliens. The clips stem from a Senate Homeland Security and Governmental Affairs Committee hearing, focused on oversight of immigration enforcement amid recent fatal incidents in Minneapolis. ? HOLY SMOKES. Sen. Ron Johnson starts YELLING at AG Keith Ellison for exploiting the deaths of anti-ICE agitators Renee Good and Alex Pretti "A tragedy was going to happen and YOU ENCOURAGED IT! You ought to feel DAMN GUILTY about it!" "2 people are DEAD because you… pic.twitter.com/tG1VQd9PO5 — Eric Daugherty (@EricLDaugh) February 12, 2026 In one segment, Johnson accuses Ellison of fueling the chaos that resulted in the deaths of Renee Good and Alex Pretti. “A tragedy was going to happen and YOU ENCOURAGED IT! You ought to feel DAMN GUILTY about it!” Johnson shouts. He continues: “two people are DEAD because you encouraged them to put themselves in harm’s way. And now you EXPLOIT those 2 people. It never should’ve happened!” Johnson paints a vivid picture of the dangers faced by ICE agents: “I can’t imagine being a law enforcement official where I know my colleagues have been shot at, their vehicles rammed, that there are trained activists deployed.” “And by the way, we know at least one of those activists had a semi-automatic pistol with extra clips!” Johnson adds. “So now you’re an ICE officer. You’re doing enforcement action. You’ve got a team behind you trying to protect you,” he continues, urging “You’ve got all these trained activis...
Oura has taken to Washington to lobby for relaxed wearable regulation. This is Optimizer , a weekly newsletter sent every Friday from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life . Opt in for Optimizer here . For the past week, I've been thinking about the fact that Oura has gone to Washington. The Oura R...
Oura has taken to Washington to lobby for relaxed wearable regulation. This is Optimizer , a weekly newsletter sent every Friday from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life . Opt in for Optimizer here . For the past week, I've been thinking about the fact that Oura has gone to Washington. The Oura Ring has always had an influential clientele , but it's apparently now a popular accessory in Capitol Hill. Earlier this week, Politico ran a story about how the smart ring maker is lobbying legislators for less wearable regulation. Specifically, the article notes that Oura has floated the idea of creating a "digital heal … Read the full story at The Verge.
Investors are laser-focused on the ongoing artificial intelligence (AI) boom, as they figure out ways to gain exposure to what could shake out to be a game-changing tech trend. There might be solid opportunities right under your nose. Take a closer look at Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) , whose shares are trading 6% off their high (as of Feb. 9). Should you buy the dip? Image source: Alph...
Investors are laser-focused on the ongoing artificial intelligence (AI) boom, as they figure out ways to gain exposure to what could shake out to be a game-changing tech trend. There might be solid opportunities right under your nose. Take a closer look at Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) , whose shares are trading 6% off their high (as of Feb. 9). Should you buy the dip? Image source: Alphabet. Continue reading